Larvol Delta - CNS-Pharmaceuticals-to-Discuss-Phase-2-Clinical-Trial-Design-to-be-Submitted-for-FDA-Review-in-Webcast-at-430-PM-ET-Today

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://www.prnewswire.com/news-releases/cns-pharmaceuticals-to-discuss-phase-2-clinical-trial-design-to-be-submitted-for-fda-review-in-webcast-at-430-pm-et-today-301171565.html

Nov 12, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next